MEDICURE INC (MPH.CA) Stock Price & Overview
TSX-V:MPH • CA58469E4085
The current stock price of MPH.CA is 0.97 CAD. Today MPH.CA is down by -13.39%. In the past month the price decreased by -17.8%. In the past year, price decreased by -4.9%.
MPH.CA Key Statistics
- Market Cap
- 10.127M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.33
- Dividend Yield
- N/A
MPH.CA Stock Performance
MPH.CA Stock Chart
MPH.CA Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to MPH.CA. When comparing the yearly performance of all stocks, MPH.CA is a bad performer in the overall market: 89.52% of all stocks are doing better.
MPH.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to MPH.CA. While MPH.CA seems to be doing ok healthwise, there are quite some concerns on its profitability.
MPH.CA Earnings
On November 19, 2025 MPH.CA reported an EPS of -0.13 and a revenue of 8.33M.
MPH.CA Forecast & Estimates
MPH.CA Groups
Sector & Classification
MPH.CA Financial Highlights
Over the last trailing twelve months MPH.CA reported a non-GAAP Earnings per Share(EPS) of -0.33. The EPS decreased by -68.69% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -12.83% | ||
| ROE | -19.81% | ||
| Debt/Equity | 0.03 |
MPH.CA Ownership
MPH.CA Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| EPRX | EUPRAXIA PHARMACEUTICALS INC | N/A | 634.207M | ||
| EDT | SPECTRAL MEDICAL INC | N/A | 380.328M | ||
| HBP | HELIX BIOPHARMA CORP | N/A | 141.303M | ||
| MDNA | MEDICENNA THERAPEUTICS CORP | N/A | 71.733M | ||
| COV | COVALON TECHNOLOGIES LTD | 12.62 | 50.268M | ||
| BCT | BRIACELL THERAPEUTICS CORP | N/A | 36.758M | ||
| RVX | RESVERLOGIX CORP | N/A | 34.526M | ||
| MBX | MICROBIX BIOSYSTEMS INC | 3.25 | 31.867M | ||
| HEM | HEMOSTEMIX INC | N/A | 16.596M | ||
| CSCI | COSCIENS BIOPHARMA INC | N/A | 6.837M | ||
| KNE | KANE BIOTECH INC | N/A | 6.356M | ||
| QPT | QUEST PHARMATECH INC | N/A | 5.92M |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the TSX Venture Exchange Exchange | Find stocks with similar TA and Setup ratings on the Canadian exchanges | Find stocks with similar Fundamental rating on the Canadian exchanges | Find the competitors with the best technical ratings on the Canadian exchanges | Find the competitors with the best fundamentals on the Canadian exchanges | Find the competitors with the best valuation on the Canadian exchanges | Find the competitors with the best dividend on the Canadian exchanges | Find the competitors with the best analyst ratings on the Canadian exchanges
About MPH.CA
Company Profile
Medicure, Inc. is a pharmaceutical company, which engages in the research, clinical development, and commercialization of cardiovascular therapeutics. The company is headquartered in Winnipeg, Manitoba and currently employs 23 full-time employees. Its primary focus is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through its United States subsidiary, Medicure Pharma Inc. The company operates Marley Drug Inc. (Marley Drug), a pharmacy subsidiary servicing all 50 states, Washington D.C. and Puerto Rico. Marley Drug is committed to improving access to medications for all Americans, together with customer service and free home delivery. The company operates Gateway Medical Pharmacy, located in Portland, Oregon in a medical office building near transportation lines and multiple healthcare clinics and centers. The company develops pyridoxal 5'-phosphate analogues (P5P Analogues), the processes for their preparation, and compositions containing P5P Analogues.
Company Info
IPO: 1999-03-30
MEDICURE INC
1250 Waverley Street
Winnipeg MANITOBA R3T 6C6 CA
CEO: Albert D. Friesen
Employees: 38
Phone: 12044877412
MEDICURE INC / MPH.CA FAQ
Can you describe the business of MEDICURE INC?
Medicure, Inc. is a pharmaceutical company, which engages in the research, clinical development, and commercialization of cardiovascular therapeutics. The company is headquartered in Winnipeg, Manitoba and currently employs 23 full-time employees. Its primary focus is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through its United States subsidiary, Medicure Pharma Inc. The company operates Marley Drug Inc. (Marley Drug), a pharmacy subsidiary servicing all 50 states, Washington D.C. and Puerto Rico. Marley Drug is committed to improving access to medications for all Americans, together with customer service and free home delivery. The company operates Gateway Medical Pharmacy, located in Portland, Oregon in a medical office building near transportation lines and multiple healthcare clinics and centers. The company develops pyridoxal 5'-phosphate analogues (P5P Analogues), the processes for their preparation, and compositions containing P5P Analogues.
What is the current price of MPH stock?
The current stock price of MPH.CA is 0.97 CAD. The price decreased by -13.39% in the last trading session.
Does MPH stock pay dividends?
MPH.CA does not pay a dividend.
What is the ChartMill rating of MEDICURE INC stock?
MPH.CA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
How is the valuation of MEDICURE INC (MPH.CA) based on its PE ratio?
MEDICURE INC (MPH.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.33).
What is the ownership structure of MEDICURE INC (MPH.CA)?
You can find the ownership structure of MEDICURE INC (MPH.CA) on the Ownership tab.